Deliver Your News to the World

Call Conference - Hemispherx BioPharma Inc.


Hemispherx BioPharma Inc.

(Public, AMEX:HEB)

At approximately 4:30pm EST, 5/15/09, StocksHaven Investments began the call conference scheduled with Chairman & CEO of Hemispherx BioPharma Inc., Dr. William Carter. The interview process was a tremendous success and was concluded as of 5:00pm EST, 5/15/09. Many issues and concerns of private individual investors were raised and answered in a both informative and intellectual manner by Dr. Carter.

The exclusive StocksHaven Investments interview:

Please visit to listen to the Call Conference.

In addition, StocksHaven Investments would like to thank all of the contributors who have helped facilitate and assist with this conference.

About StocksHaven Investments

StocksHaven Investments can be found at It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, discussion forum, stock research reports, news feeds, mailing list, videos, press release capability, stock commentaries, and other unique content - including expert stock analysis from Michael Vlaicu.

For more financial and investment news, go to


 heb call conference
 hemispherx biopharma call
 stockshaven heb call
 stock symbol heb

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.